Illumination Acquisition I, a special purpose acquisition company sponsored by Lucid Capital Markets, has filed to raise up to $200 million in an initial public...
Zeta Global Holdings Corp. continues to attract investor attention as enterprises deepen spending on data-driven marketing and artificial intelligence. The New York–based technology firm...
Travere Therapeutics, Inc. has evolved into a highly specialized public biotechnology company targeting rare kidney and metabolic diseases, positioning itself as a differentiated player...
UiPath Inc. (NYSE: PATH) has evolved significantly since its public market debut, emerging as a central player in enterprise automation as organizations accelerate digital...